Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
22201
22202
22203
22204
22205
22206
22207
22208
22209
22210
22211
22212
22213
22214
22215
22216
22217
22218
22219
22220
22221
22222
22223
22224
22225
22226
22227
22228
22229
22230
22231
22232
22233
22234
22235
22236
22237
22238
22239
22240
22241
22242
22243
22244
22245
22246
22247
22248
22249
22250
22251
22252
22253
22254
22255
22256
22257
22258
22259
22260
22261
22262
22263
22264
22265
22266
22267
22268
22269
22270
22271
22272
22273
22274
22275
22276
22277
22278
22279
22280
22281
22282
22283
22284
22285
22286
22287
22288
22289
22290
22291
22292
22293
22294
22295
22296
22297
22298
22299
22300
22301
22302
22303
22304
22305
22306
22307
22308
22309
22310
22311
22312
22313
22314
22315
22316
22317
22318
22319
22320
22321
22322
22323
22324
22325
22326
22327
22328
22329
22330
22331
22332
22333
22334
22335
22336
22337
22338
22339
22340
22341
22342
22343
22344
22345
22346
22347
22348
22349
22350
22351
22352
22353
22354
22355
22356
22357
22358
22359
22360
22361
22362
22363
22364
22365
22366
22367
22368
22369
22370
22371
22372
22373
22374
22375
22376
22377
22378
22379
22380
22381
22382
22383
22384
22385
22386
22387
22388
22389
22390
22391
22392
22393
22394
22395
22396
22397
22398
22399
22400
| UnnamedSample_HQ_transcript/9767|m.3754 | UnnamedSample_HQ_transcript/9767 | Coverage 0.701 too low. | ca10edfb8ec6087eb61a9ee30668d58c | 1230 | Pfam | PF00595 | PDZ domain | 62 | 133 | 8.8E-18 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/9767|m.3754 | UnnamedSample_HQ_transcript/9767 | Coverage 0.701 too low. | ca10edfb8ec6087eb61a9ee30668d58c | 1230 | Pfam | PF00621 | RhoGEF domain | 1072 | 1230 | 7.4E-34 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/9767|m.3754 | UnnamedSample_HQ_transcript/9767 | Coverage 0.701 too low. | ca10edfb8ec6087eb61a9ee30668d58c | 1230 | Pfam | PF09128 | Regulator of G protein signalling-like domain | 532 | 719 | 8.4E-50 | T | 22-09-2020 | IPR015212 | Regulator of G protein signalling-like domain |
| UnnamedSample_HQ_transcript/9767|m.3754 | UnnamedSample_HQ_transcript/9767 | Coverage 0.701 too low. | ca10edfb8ec6087eb61a9ee30668d58c | 1230 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 761 | 811 | 3.2E-11 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/20447|m.6986 | UnnamedSample_HQ_transcript/20447 | Coverage 0.746 too low. | aead53640d6e1c8d9bb9e80a073c7625 | 571 | Pfam | PF18701 | Family of unknown function (DUF5641) | 469 | 562 | 7.2E-34 | T | 22-09-2020 | IPR040676 | Domain of unknown function DUF5641 |
| UnnamedSample_HQ_transcript/88882|m.21068 | UnnamedSample_HQ_transcript/88882 | Coverage 0.652 too low. | 38f418f1b4a6413aa2a42c517b199ee2 | 355 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 45 | 136 | 3.2E-20 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/88882|m.21068 | UnnamedSample_HQ_transcript/88882 | Coverage 0.652 too low. | 38f418f1b4a6413aa2a42c517b199ee2 | 355 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 239 | 349 | 1.0E-21 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/21581|m.7303 | UnnamedSample_HQ_transcript/21581 | Coverage 0.924 too low. | 60afe0f78758bb124fe429caa5d044f2 | 811 | Pfam | PF01074 | Glycosyl hydrolases family 38 N-terminal domain | 41 | 355 | 6.0E-92 | T | 22-09-2020 | IPR000602 | Glycoside hydrolase family 38, N-terminal domain |
| UnnamedSample_HQ_transcript/21581|m.7303 | UnnamedSample_HQ_transcript/21581 | Coverage 0.924 too low. | 60afe0f78758bb124fe429caa5d044f2 | 811 | Pfam | PF07748 | Glycosyl hydrolases family 38 C-terminal domain | 581 | 787 | 2.3E-39 | T | 22-09-2020 | IPR011682 | Glycosyl hydrolase family 38, C-terminal |
| UnnamedSample_HQ_transcript/21581|m.7303 | UnnamedSample_HQ_transcript/21581 | Coverage 0.924 too low. | 60afe0f78758bb124fe429caa5d044f2 | 811 | Pfam | PF09261 | Alpha mannosidase middle domain | 360 | 451 | 4.9E-19 | T | 22-09-2020 | IPR015341 | Glycoside hydrolase family 38, central domain |
| UnnamedSample_HQ_transcript/107095|m.23476 | UnnamedSample_HQ_transcript/107095 | Coverage 0.987 too low. | f1e6850a01dbd63de71d586b291deef1 | 147 | Pfam | PF00755 | Choline/Carnitine o-acyltransferase | 2 | 140 | 1.1E-41 | T | 22-09-2020 | IPR039551 | Choline/carnitine acyltransferase domain |
| UnnamedSample_HQ_transcript/26741|m.8661 | UnnamedSample_HQ_transcript/26741 | Unmapped. | 47c273ade1596d71abb41acdc50994cf | 959 | Pfam | PF00946 | Mononegavirales RNA dependent RNA polymerase | 3 | 753 | 1.9E-150 | T | 22-09-2020 | IPR014023 | Mononegavirales RNA-directed RNA polymerase catalytic domain |
| UnnamedSample_HQ_transcript/26741|m.8661 | UnnamedSample_HQ_transcript/26741 | Unmapped. | 47c273ade1596d71abb41acdc50994cf | 959 | Pfam | PF14318 | Mononegavirales mRNA-capping region V | 773 | 958 | 3.2E-36 | T | 22-09-2020 | IPR026890 | Mononegavirales mRNA-capping domain V |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12661 | Human growth factor-like EGF | 285 | 303 | 0.029 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07474 | G2F domain | 2 | 124 | 2.3E-31 | T | 22-09-2020 | IPR006605 | G2 nidogen/fibulin G2F |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07645 | Calcium-binding EGF domain | 226 | 261 | 3.6E-11 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07645 | Calcium-binding EGF domain | 319 | 360 | 1.0E-6 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12947 | EGF domain | 449 | 486 | 6.1E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12947 | EGF domain | 656 | 692 | 4.9E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 745 | 785 | 1.5E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 789 | 828 | 1.3E-13 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/22057|m.7441 | UnnamedSample_HQ_transcript/22057 | Identity 0.813 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 831 | 874 | 8.9E-9 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12661 | Human growth factor-like EGF | 285 | 303 | 0.029 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07474 | G2F domain | 2 | 124 | 2.3E-31 | T | 22-09-2020 | IPR006605 | G2 nidogen/fibulin G2F |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07645 | Calcium-binding EGF domain | 226 | 261 | 3.6E-11 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07645 | Calcium-binding EGF domain | 319 | 360 | 1.0E-6 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12947 | EGF domain | 449 | 486 | 6.1E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12947 | EGF domain | 656 | 692 | 4.9E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 745 | 785 | 1.5E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 789 | 828 | 1.3E-13 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/18008|m.6302 | UnnamedSample_HQ_transcript/18008 | Identity 0.826 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 831 | 874 | 8.9E-9 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12661 | Human growth factor-like EGF | 285 | 303 | 0.029 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07474 | G2F domain | 2 | 124 | 2.3E-31 | T | 22-09-2020 | IPR006605 | G2 nidogen/fibulin G2F |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07645 | Calcium-binding EGF domain | 226 | 261 | 3.6E-11 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07645 | Calcium-binding EGF domain | 319 | 360 | 1.0E-6 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12947 | EGF domain | 449 | 486 | 6.1E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12947 | EGF domain | 656 | 692 | 4.9E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 745 | 785 | 1.5E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 789 | 828 | 1.3E-13 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/16314|m.5800 | UnnamedSample_HQ_transcript/16314 | Identity 0.832 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 831 | 874 | 8.9E-9 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12661 | Human growth factor-like EGF | 285 | 303 | 0.029 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07474 | G2F domain | 2 | 124 | 2.3E-31 | T | 22-09-2020 | IPR006605 | G2 nidogen/fibulin G2F |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07645 | Calcium-binding EGF domain | 226 | 261 | 3.6E-11 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF07645 | Calcium-binding EGF domain | 319 | 360 | 1.0E-6 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12947 | EGF domain | 449 | 486 | 6.1E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF12947 | EGF domain | 656 | 692 | 4.9E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 745 | 785 | 1.5E-7 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 789 | 828 | 1.3E-13 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/14682|m.5320 | UnnamedSample_HQ_transcript/14682 | Identity 0.837 too low. | f1a610dd8a5b3e22f32a481c21d66463 | 962 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 831 | 874 | 8.9E-9 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/28999|m.9227 | UnnamedSample_HQ_transcript/28999 | Coverage 0.982 too low. | 0e73a89ad9c5d3ae2ac6c5c4bca914e6 | 836 | Pfam | PF01576 | Myosin tail | 1 | 835 | 2.0E-127 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/53697|m.14784 | UnnamedSample_HQ_transcript/53697 | Coverage 0.933 too low. | 7d7e1b99e28114f66e165dd3785e4dac | 645 | Pfam | PF09820 | Predicted AAA-ATPase | 34 | 345 | 1.8E-15 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/6720|m.2780 | UnnamedSample_HQ_transcript/6720 | Coverage 0.948 too low. | f5b03d4214aeb4bb9a245215cdb85f3c | 556 | Pfam | PF10267 | Predicted transmembrane and coiled-coil 2 protein | 116 | 536 | 3.0E-158 | T | 22-09-2020 | IPR019394 | Testis-specific protein TEX28/transmembrane and coiled-coil domains protein |
| UnnamedSample_HQ_transcript/40415|m.11942 | UnnamedSample_HQ_transcript/40415 | Coverage 0.878 too low. | f5b03d4214aeb4bb9a245215cdb85f3c | 556 | Pfam | PF10267 | Predicted transmembrane and coiled-coil 2 protein | 116 | 536 | 3.0E-158 | T | 22-09-2020 | IPR019394 | Testis-specific protein TEX28/transmembrane and coiled-coil domains protein |
| UnnamedSample_HQ_transcript/24304|m.8022 | UnnamedSample_HQ_transcript/24304 | Coverage 0.823 too low. | 0b04f00ecd5223139302693eec9dbc0b | 820 | Pfam | PF00168 | C2 domain | 662 | 780 | 8.6E-7 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/102864|m.22975 | UnnamedSample_HQ_transcript/102864 | Unmapped. | bd326ac1ca72e7c6e78ceb75ac80df3c | 356 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 17 | 337 | 3.8E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/78277|m.19421 | UnnamedSample_HQ_transcript/78277 | Coverage 0.316 too low. | 2a0b877f18e08bdec7d4f3603ac458bc | 452 | Pfam | PF07766 | LETM1-like protein | 146 | 410 | 1.9E-103 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/8066|m.3212 | UnnamedSample_HQ_transcript/8066 | Identity 0.672 too low. | f0dda2ad87f639c6d965f3a167dd61cf | 1371 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 6.9E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/8066|m.3212 | UnnamedSample_HQ_transcript/8066 | Identity 0.672 too low. | f0dda2ad87f639c6d965f3a167dd61cf | 1371 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 5.9E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/85689|m.20597 | UnnamedSample_HQ_transcript/85689 | Coverage 0.984 too low. | 9ae68aec64dd5c0ed17d1040cdfdfeb3 | 205 | Pfam | PF00297 | Ribosomal protein L3 | 5 | 190 | 3.2E-88 | T | 22-09-2020 | IPR000597 | Ribosomal protein L3 |
| UnnamedSample_HQ_transcript/33049|m.10223 | UnnamedSample_HQ_transcript/33049 | Identity 0.940 too low. | 964978412dbfbee08228ac388c7d069d | 753 | Pfam | PF01044 | Vinculin family | 1 | 751 | 3.1E-272 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/120583|m.24887 | UnnamedSample_HQ_transcript/120583 | Coverage 0.759 too low. | 4dc0ec41f33ee9638e61f35a2e72384b | 125 | Pfam | PF00704 | Glycosyl hydrolases family 18 | 26 | 113 | 1.7E-9 | T | 22-09-2020 | IPR001223 | Glycoside hydrolase family 18, catalytic domain |
| UnnamedSample_HQ_transcript/39247|m.11699 | UnnamedSample_HQ_transcript/39247 | Identity 0.751 too low. | e921c4fb05a7532df487eeaaf052d174 | 503 | Pfam | PF00412 | LIM domain | 327 | 381 | 2.8E-17 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/39247|m.11699 | UnnamedSample_HQ_transcript/39247 | Identity 0.751 too low. | e921c4fb05a7532df487eeaaf052d174 | 503 | Pfam | PF00412 | LIM domain | 386 | 441 | 1.4E-16 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/39247|m.11699 | UnnamedSample_HQ_transcript/39247 | Identity 0.751 too low. | e921c4fb05a7532df487eeaaf052d174 | 503 | Pfam | PF00412 | LIM domain | 445 | 495 | 5.2E-12 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/65937|m.17194 | UnnamedSample_HQ_transcript/65937 | Coverage 0.722 too low. | 6ad748f2947fe22d03c818119d06a717 | 465 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.6E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/64309|m.16910 | UnnamedSample_HQ_transcript/64309 | Coverage 0.780 too low. | 0ff1a263da525622a7113de78a3f590b | 432 | Pfam | PF00135 | Carboxylesterase family | 1 | 412 | 3.4E-96 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/104529|m.23170 | UnnamedSample_HQ_transcript/104529 | Coverage 0.989 too low. | c0876d9e3e6eac9b356ced5ae5409eb0 | 290 | Pfam | PF00194 | Eukaryotic-type carbonic anhydrase | 32 | 272 | 2.6E-20 | T | 22-09-2020 | IPR001148 | Alpha carbonic anhydrase domain |
| UnnamedSample_HQ_transcript/91610|m.21488 | UnnamedSample_HQ_transcript/91610 | Coverage 0.931 too low. | d12a287adca8c46e85ed92e8e6c63fd8 | 232 | Pfam | PF03723 | Hemocyanin, ig-like domain | 1 | 164 | 2.1E-40 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/110512|m.23896 | UnnamedSample_HQ_transcript/110512 | Coverage 0.978 too low. | 414c1cb5aa69a1622d8292e5917b74e3 | 159 | Pfam | PF03501 | Plectin/S10 domain | 3 | 95 | 6.5E-46 | T | 22-09-2020 | IPR005326 | Plectin/S10, N-terminal |
| UnnamedSample_HQ_transcript/114611|m.24361 | UnnamedSample_HQ_transcript/114611 | Coverage 0.976 too low. | 414c1cb5aa69a1622d8292e5917b74e3 | 159 | Pfam | PF03501 | Plectin/S10 domain | 3 | 95 | 6.5E-46 | T | 22-09-2020 | IPR005326 | Plectin/S10, N-terminal |
| UnnamedSample_HQ_transcript/116293|m.24517 | UnnamedSample_HQ_transcript/116293 | Coverage 0.971 too low. | 414c1cb5aa69a1622d8292e5917b74e3 | 159 | Pfam | PF03501 | Plectin/S10 domain | 3 | 95 | 6.5E-46 | T | 22-09-2020 | IPR005326 | Plectin/S10, N-terminal |
| UnnamedSample_HQ_transcript/120724|m.24895 | UnnamedSample_HQ_transcript/120724 | Coverage 0.965 too low. | 414c1cb5aa69a1622d8292e5917b74e3 | 159 | Pfam | PF03501 | Plectin/S10 domain | 3 | 95 | 6.5E-46 | T | 22-09-2020 | IPR005326 | Plectin/S10, N-terminal |
| UnnamedSample_HQ_transcript/35537|m.10829 | UnnamedSample_HQ_transcript/35537 | Coverage 0.971 too low. | 1884b53c3674cf92d9943e6f0c934d0c | 612 | Pfam | PF00569 | Zinc finger, ZZ type | 298 | 341 | 1.4E-16 | T | 22-09-2020 | IPR000433 | Zinc finger, ZZ-type |
| UnnamedSample_HQ_transcript/35537|m.10829 | UnnamedSample_HQ_transcript/35537 | Coverage 0.971 too low. | 1884b53c3674cf92d9943e6f0c934d0c | 612 | Pfam | PF09069 | EF-hand | 200 | 292 | 6.0E-39 | T | 22-09-2020 | IPR015154 | EF-hand domain, type 2 |
| UnnamedSample_HQ_transcript/35537|m.10829 | UnnamedSample_HQ_transcript/35537 | Coverage 0.971 too low. | 1884b53c3674cf92d9943e6f0c934d0c | 612 | Pfam | PF09068 | EF hand | 78 | 196 | 1.3E-39 | T | 22-09-2020 | IPR015153 | EF-hand domain, type 1 |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 47 | 137 | 2.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 919 | 991 | 8.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1127 | 1215 | 3.7E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 439 | 521 | 1.0E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 618 | 704 | 5.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 375 | 429 | 1.2E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 3 | 40 | 2.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 247 | 326 | 6.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 720 | 802 | 2.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 144 | 235 | 1.4E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 813 | 897 | 2.6E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3916|m.1780 | UnnamedSample_HQ_transcript/3916 | Coverage 0.367 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1000 | 1085 | 9.4E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 47 | 137 | 2.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 919 | 991 | 8.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1127 | 1215 | 3.7E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 439 | 521 | 1.0E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 618 | 704 | 5.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 375 | 429 | 1.2E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 3 | 40 | 2.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 247 | 326 | 6.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 720 | 802 | 2.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 144 | 235 | 1.4E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 813 | 897 | 2.6E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/3578|m.1644 | UnnamedSample_HQ_transcript/3578 | Coverage 0.387 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1000 | 1085 | 9.4E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 47 | 137 | 2.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 919 | 991 | 8.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1127 | 1215 | 3.7E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 439 | 521 | 1.0E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 618 | 704 | 5.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 375 | 429 | 1.2E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 3 | 40 | 2.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 247 | 326 | 6.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 720 | 802 | 2.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 144 | 235 | 1.4E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 813 | 897 | 2.6E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6118|m.2581 | UnnamedSample_HQ_transcript/6118 | Coverage 0.305 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1000 | 1085 | 9.4E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 47 | 137 | 2.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 919 | 991 | 8.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1127 | 1215 | 3.7E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 439 | 521 | 1.0E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 618 | 704 | 5.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 375 | 429 | 1.2E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 3 | 40 | 2.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 247 | 326 | 6.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 720 | 802 | 2.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 144 | 235 | 1.4E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 813 | 897 | 2.6E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/6972|m.2850 | UnnamedSample_HQ_transcript/6972 | Coverage 0.288 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1000 | 1085 | 9.4E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 47 | 137 | 2.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 919 | 991 | 8.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1127 | 1215 | 3.7E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 439 | 521 | 1.0E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 618 | 704 | 5.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 375 | 429 | 1.2E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 3 | 40 | 2.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 247 | 326 | 6.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 720 | 802 | 2.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 144 | 235 | 1.4E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 813 | 897 | 2.6E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/5293|m.2294 | UnnamedSample_HQ_transcript/5293 | Coverage 0.330 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1000 | 1085 | 9.4E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 47 | 137 | 2.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 919 | 991 | 8.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1127 | 1215 | 3.7E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 439 | 521 | 1.0E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 618 | 704 | 5.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 375 | 429 | 1.2E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 3 | 40 | 2.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 247 | 326 | 6.6E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 720 | 802 | 2.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 144 | 235 | 1.4E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 813 | 897 | 2.6E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/467|m.350 | UnnamedSample_HQ_transcript/467 | Coverage 0.581 too low. | c42e0777fe7991a646252d20cdeb6967 | 1218 | Pfam | PF00630 | Filamin/ABP280 repeat | 1000 | 1085 | 9.4E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/73877|m.18626 | UnnamedSample_HQ_transcript/73877 | Coverage 0.896 too low. | baceacfe329adf57244e5b8bf9752494 | 299 | Pfam | PF00046 | Homeodomain | 252 | 299 | 2.8E-15 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/81298|m.19934 | UnnamedSample_HQ_transcript/81298 | Coverage 0.890 too low. | baceacfe329adf57244e5b8bf9752494 | 299 | Pfam | PF00046 | Homeodomain | 252 | 299 | 2.8E-15 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/6224|m.2614 | UnnamedSample_HQ_transcript/6224 | Coverage 0.895 too low. | 319f1790af03ff1332aed75b6a9a119a | 458 | Pfam | PF08075 | NOPS (NUC059) domain | 285 | 337 | 6.7E-24 | T | 22-09-2020 | IPR012975 | NOPS |
| UnnamedSample_HQ_transcript/6224|m.2614 | UnnamedSample_HQ_transcript/6224 | Coverage 0.895 too low. | 319f1790af03ff1332aed75b6a9a119a | 458 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 215 | 272 | 3.1E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/6224|m.2614 | UnnamedSample_HQ_transcript/6224 | Coverage 0.895 too low. | 319f1790af03ff1332aed75b6a9a119a | 458 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 141 | 204 | 9.3E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/76146|m.19052 | UnnamedSample_HQ_transcript/76146 | Coverage 0.867 too low. | 9b362c8d0a443d5a64f20b04c94111d0 | 412 | Pfam | PF02958 | Ecdysteroid kinase | 39 | 327 | 6.1E-60 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/108331|m.23618 | UnnamedSample_HQ_transcript/108331 | Coverage 0.513 too low. | f6d1650e5efc3e524bf67685bb33ad5c | 206 | Pfam | PF02198 | Sterile alpha motif (SAM)/Pointed domain | 124 | 205 | 1.2E-32 | T | 22-09-2020 | IPR003118 | Pointed domain |
| UnnamedSample_HQ_transcript/110616|m.23914 | UnnamedSample_HQ_transcript/110616 | Coverage 0.980 too low. | 2774f39cf7f1a53fceac819ce9c270e4 | 233 | Pfam | PF00567 | Tudor domain | 153 | 231 | 1.2E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/110616|m.23914 | UnnamedSample_HQ_transcript/110616 | Coverage 0.980 too low. | 2774f39cf7f1a53fceac819ce9c270e4 | 233 | Pfam | PF00567 | Tudor domain | 6 | 59 | 1.6E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/24127|m.7979 | UnnamedSample_HQ_transcript/24127 | Coverage 0.985 too low. | 660dd6bffc48bfcb422fe60129b2fa05 | 882 | Pfam | PF00493 | MCM P-loop domain | 440 | 662 | 4.6E-100 | T | 22-09-2020 | IPR001208 | MCM domain |
| UnnamedSample_HQ_transcript/24127|m.7979 | UnnamedSample_HQ_transcript/24127 | Coverage 0.985 too low. | 660dd6bffc48bfcb422fe60129b2fa05 | 882 | Pfam | PF17855 | MCM AAA-lid domain | 691 | 775 | 5.8E-30 | T | 22-09-2020 | IPR041562 | MCM, AAA-lid domain |
| UnnamedSample_HQ_transcript/24127|m.7979 | UnnamedSample_HQ_transcript/24127 | Coverage 0.985 too low. | 660dd6bffc48bfcb422fe60129b2fa05 | 882 | Pfam | PF14551 | MCM N-terminal domain | 176 | 264 | 1.5E-17 | T | 22-09-2020 | IPR027925 | MCM N-terminal domain |
| UnnamedSample_HQ_transcript/24127|m.7979 | UnnamedSample_HQ_transcript/24127 | Coverage 0.985 too low. | 660dd6bffc48bfcb422fe60129b2fa05 | 882 | Pfam | PF12619 | Mini-chromosome maintenance protein 2 | 40 | 151 | 8.7E-20 | T | 22-09-2020 | IPR008045 | DNA replication licensing factor Mcm2 |
| UnnamedSample_HQ_transcript/24127|m.7979 | UnnamedSample_HQ_transcript/24127 | Coverage 0.985 too low. | 660dd6bffc48bfcb422fe60129b2fa05 | 882 | Pfam | PF17207 | MCM OB domain | 273 | 400 | 1.1E-36 | T | 22-09-2020 | IPR033762 | MCM OB domain |
| UnnamedSample_HQ_transcript/18758|m.6520 | UnnamedSample_HQ_transcript/18758 | Coverage 0.608 too low. | f51abbbfaaa3a89a3aa8b45f9a77d7ed | 756 | Pfam | PF01607 | Chitin binding Peritrophin-A domain | 42 | 92 | 2.2E-14 | T | 22-09-2020 | IPR002557 | Chitin binding domain |
| UnnamedSample_HQ_transcript/18758|m.6520 | UnnamedSample_HQ_transcript/18758 | Coverage 0.608 too low. | f51abbbfaaa3a89a3aa8b45f9a77d7ed | 756 | Pfam | PF01522 | Polysaccharide deacetylase | 421 | 536 | 3.1E-10 | T | 22-09-2020 | IPR002509 | NodB homology domain |
| UnnamedSample_HQ_transcript/28294|m.9040 | UnnamedSample_HQ_transcript/28294 | Coverage 0.568 too low. | f51abbbfaaa3a89a3aa8b45f9a77d7ed | 756 | Pfam | PF01607 | Chitin binding Peritrophin-A domain | 42 | 92 | 2.2E-14 | T | 22-09-2020 | IPR002557 | Chitin binding domain |
| UnnamedSample_HQ_transcript/28294|m.9040 | UnnamedSample_HQ_transcript/28294 | Coverage 0.568 too low. | f51abbbfaaa3a89a3aa8b45f9a77d7ed | 756 | Pfam | PF01522 | Polysaccharide deacetylase | 421 | 536 | 3.1E-10 | T | 22-09-2020 | IPR002509 | NodB homology domain |
| UnnamedSample_HQ_transcript/20484|m.7004 | UnnamedSample_HQ_transcript/20484 | Coverage 0.624 too low. | f51abbbfaaa3a89a3aa8b45f9a77d7ed | 756 | Pfam | PF01607 | Chitin binding Peritrophin-A domain | 42 | 92 | 2.2E-14 | T | 22-09-2020 | IPR002557 | Chitin binding domain |
| UnnamedSample_HQ_transcript/20484|m.7004 | UnnamedSample_HQ_transcript/20484 | Coverage 0.624 too low. | f51abbbfaaa3a89a3aa8b45f9a77d7ed | 756 | Pfam | PF01522 | Polysaccharide deacetylase | 421 | 536 | 3.1E-10 | T | 22-09-2020 | IPR002509 | NodB homology domain |
| UnnamedSample_HQ_transcript/35382|m.10797 | UnnamedSample_HQ_transcript/35382 | Coverage 0.964 too low. | cf860f3cf8ffce9d6c48dafdc9657453 | 486 | Pfam | PF01412 | Putative GTPase activating protein for Arf | 14 | 119 | 2.9E-32 | T | 22-09-2020 | IPR001164 | Arf GTPase activating protein |
| UnnamedSample_HQ_transcript/53939|m.14826 | UnnamedSample_HQ_transcript/53939 | Coverage 0.865 too low. | 12e6e733389d8bfb0a65209b55f47ece | 213 | Pfam | PF07993 | Male sterility protein | 26 | 186 | 5.4E-50 | T | 22-09-2020 | IPR013120 | Male sterility, NAD-binding |
| UnnamedSample_HQ_transcript/17745|m.6233 | UnnamedSample_HQ_transcript/17745 | Coverage 0.965 too low. | ff80f6872ca2889180ca5be4686ca5b9 | 1052 | Pfam | PF16519 | Tetramerisation domain of TRPM | 476 | 531 | 2.1E-19 | T | 22-09-2020 | IPR032415 | TRPM, tetramerisation domain |
| UnnamedSample_HQ_transcript/17745|m.6233 | UnnamedSample_HQ_transcript/17745 | Coverage 0.965 too low. | ff80f6872ca2889180ca5be4686ca5b9 | 1052 | Pfam | PF00520 | Ion transport protein | 151 | 385 | 1.3E-16 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/77531|m.19295 | UnnamedSample_HQ_transcript/77531 | Coverage 0.274 too low. | f83e81a472f2981c1befea082083770a | 420 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 31 | 420 | 6.5E-60 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/9647|m.3714 | UnnamedSample_HQ_transcript/9647 | Identity 0.758 too low. | 75475c43ca007f64bd4fd41bbe9bf293 | 1164 | Pfam | PF00266 | Aminotransferase class-V | 67 | 435 | 4.6E-26 | T | 22-09-2020 | IPR000192 | Aminotransferase class V domain |
| UnnamedSample_HQ_transcript/9647|m.3714 | UnnamedSample_HQ_transcript/9647 | Identity 0.758 too low. | 75475c43ca007f64bd4fd41bbe9bf293 | 1164 | Pfam | PF01171 | PP-loop family | 1072 | 1148 | 2.7E-8 | T | 22-09-2020 | IPR011063 | tRNA(Ile)-lysidine/2-thiocytidine synthase, N-terminal |
| UnnamedSample_HQ_transcript/4598|m.2035 | UnnamedSample_HQ_transcript/4598 | Coverage 0.070 too low. | 5d9d3d8627b9c48cef00b14f20d4f820 | 1500 | Pfam | PF00536 | SAM domain (Sterile alpha motif) | 1425 | 1483 | 5.9E-11 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/4598|m.2035 | UnnamedSample_HQ_transcript/4598 | Coverage 0.070 too low. | 5d9d3d8627b9c48cef00b14f20d4f820 | 1500 | Pfam | PF00595 | PDZ domain | 806 | 888 | 1.3E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/4598|m.2035 | UnnamedSample_HQ_transcript/4598 | Coverage 0.070 too low. | 5d9d3d8627b9c48cef00b14f20d4f820 | 1500 | Pfam | PF17817 | PDZ domain | 725 | 797 | 2.4E-33 | T | 22-09-2020 | IPR040645 | Neurabin-1/2, PDZ domain |
| UnnamedSample_HQ_transcript/5529|m.2368 | UnnamedSample_HQ_transcript/5529 | Coverage 0.037 too low. | 5d9d3d8627b9c48cef00b14f20d4f820 | 1500 | Pfam | PF00536 | SAM domain (Sterile alpha motif) | 1425 | 1483 | 5.9E-11 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/5529|m.2368 | UnnamedSample_HQ_transcript/5529 | Coverage 0.037 too low. | 5d9d3d8627b9c48cef00b14f20d4f820 | 1500 | Pfam | PF00595 | PDZ domain | 806 | 888 | 1.3E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/5529|m.2368 | UnnamedSample_HQ_transcript/5529 | Coverage 0.037 too low. | 5d9d3d8627b9c48cef00b14f20d4f820 | 1500 | Pfam | PF17817 | PDZ domain | 725 | 797 | 2.4E-33 | T | 22-09-2020 | IPR040645 | Neurabin-1/2, PDZ domain |
| UnnamedSample_HQ_transcript/19579|m.6752 | UnnamedSample_HQ_transcript/19579 | Coverage 0.314 too low. | fe59bf44a21b3abf3b6590c198a99632 | 719 | Pfam | PF04516 | CP2 transcription factor | 611 | 705 | 1.4E-17 | T | 22-09-2020 | IPR007604 | CP2 transcription factor |
| UnnamedSample_HQ_transcript/24485|m.8063 | UnnamedSample_HQ_transcript/24485 | Identity 0.828 too low. | 3fded8c6dc7a31bfe783b39f965cfd1e | 511 | Pfam | PF07910 | Peptidase family C78 | 271 | 486 | 2.1E-55 | T | 22-09-2020 | IPR012462 | Peptidase C78, ubiquitin fold modifier-specific peptidase 1/ 2 |
| UnnamedSample_HQ_transcript/46468|m.13251 | UnnamedSample_HQ_transcript/46468 | Identity 0.825 too low. | 3fded8c6dc7a31bfe783b39f965cfd1e | 511 | Pfam | PF07910 | Peptidase family C78 | 271 | 486 | 2.1E-55 | T | 22-09-2020 | IPR012462 | Peptidase C78, ubiquitin fold modifier-specific peptidase 1/ 2 |
| UnnamedSample_HQ_transcript/24805|m.8169 | UnnamedSample_HQ_transcript/24805 | Identity 0.843 too low. | 3fded8c6dc7a31bfe783b39f965cfd1e | 511 | Pfam | PF07910 | Peptidase family C78 | 271 | 486 | 2.1E-55 | T | 22-09-2020 | IPR012462 | Peptidase C78, ubiquitin fold modifier-specific peptidase 1/ 2 |
| UnnamedSample_HQ_transcript/42058|m.12277 | UnnamedSample_HQ_transcript/42058 | Identity 0.910 too low. | cc54674ef538d2f0d217a7b883f8868c | 406 | Pfam | PF06031 | SERTA motif | 141 | 175 | 2.6E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/37476|m.11267 | UnnamedSample_HQ_transcript/37476 | Identity 0.915 too low. | cc54674ef538d2f0d217a7b883f8868c | 406 | Pfam | PF06031 | SERTA motif | 141 | 175 | 2.6E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/37912|m.11377 | UnnamedSample_HQ_transcript/37912 | Coverage 0.719 too low. | cc54674ef538d2f0d217a7b883f8868c | 406 | Pfam | PF06031 | SERTA motif | 141 | 175 | 2.6E-15 | T | 22-09-2020 | IPR009263 | SERTA domain |
| UnnamedSample_HQ_transcript/16326|m.5807 | UnnamedSample_HQ_transcript/16326 | Coverage 0.984 too low. | 8439dadc9e7d2001578b911c50bbd4d4 | 605 | Pfam | PF16563 | Coiled-coil and interaction region of P66A and P66B with MBD2 | 29 | 66 | 4.9E-16 | T | 22-09-2020 | IPR032346 | Transcriptional repressor p66, coiled-coil MBD2-interaction domain |
| UnnamedSample_HQ_transcript/14831|m.5362 | UnnamedSample_HQ_transcript/14831 | Coverage 0.795 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/25031|m.8228 | UnnamedSample_HQ_transcript/25031 | Coverage 0.734 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/26994|m.8716 | UnnamedSample_HQ_transcript/26994 | Coverage 0.769 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/22922|m.7670 | UnnamedSample_HQ_transcript/22922 | Coverage 0.720 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/18777|m.6524 | UnnamedSample_HQ_transcript/18777 | Coverage 0.819 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/13779|m.5043 | UnnamedSample_HQ_transcript/13779 | Coverage 0.743 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/23070|m.7708 | UnnamedSample_HQ_transcript/23070 | Coverage 0.782 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/26514|m.8608 | UnnamedSample_HQ_transcript/26514 | Coverage 0.821 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/12187|m.4551 | UnnamedSample_HQ_transcript/12187 | Coverage 0.716 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/17605|m.6193 | UnnamedSample_HQ_transcript/17605 | Coverage 0.701 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/31546|m.9845 | UnnamedSample_HQ_transcript/31546 | Coverage 0.805 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/15075|m.5425 | UnnamedSample_HQ_transcript/15075 | Coverage 0.807 too low. | 46c34fa7241bbacbbf3f8cd0d1492edf | 880 | Pfam | PF01576 | Myosin tail | 36 | 850 | 1.1E-78 | T | 22-09-2020 | IPR002928 | Myosin tail |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
